Atlantic Union Bankshares’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Atlantic Union Bankshares’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.83K	Hold	1,000	–	–	﹤0.01%	1430
2025 Q4	$7.3K	Buy	+1,000	New	+$10.9K	﹤0.01%	1326

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Atlantic Union Bankshares's QNTM Position: Q1 2026 in Review

Atlantic Union Bankshares held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 1,000 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Atlantic Union Bankshares first reported a position in QNTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.3K in Q4 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

Atlantic Union Bankshares held 1,000 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $4.83K as of Q1 2026.
Atlantic Union Bankshares left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #1430 holding.
Atlantic Union Bankshares first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2025 and has held it in 2 quarters since.
Atlantic Union Bankshares's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $7.3K in Q4 2025.
25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.